Is Semax legal?
Not as a drug. Semax has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. It is approved in Russia, which has no effect in the US. Under an interim HHS policy of 28 October 2026, a licensed pharmacy may compound it against a prescription, by set routes and under strict conditions, without federal enforcement. That policy does not cover research-use-only vials sold online.
DESCRIBES THE LAW · NOT LEGAL ADVICE · NO DOSING INFORMATION
Federal, compounding and sport status
CHECKED 1 NOV 2026Federal status
- Jul 24, 2026 · recommended · 8 yes, 5 no, 1 abstention (law-firm reports) · SOURCE ↗
Sport-body status
What we couldn’t verify

State rules
1 STATESince 1 Jul 2026 Indiana law (IC 16-42-22.5) bars compounding from research-grade or veterinary-grade bulk ingredients outside an IRB-approved study and requires an FDA-registered source with a certificate of analysis. From 1 Jan 2027 medical spas must register with the state medical board. This matters if FDA later allows pharmacies to compound Semax: in Indiana the ingredient could not be research grade.
- Indiana Senate Enrolled Act 282 (Public Law 136-2026), signed 5 Mar 2026 ↗ · verified Oct 12, 2026
- SEA 282 enrolled text ↗ · verified Oct 12, 2026
In the other states we found nothing that names Semax; federal law applies.
What changed at the last check
5 CHANGES| Date | Field | Was | Now | Why |
|---|---|---|---|---|
| 1 Nov 2026 | 503A compounding (HHS policy) | not compoundable; reported HHS stopgap not issued | HHS enforcement discretion under conditions (interim, not on Bulks List) | HHS filed its peptide enforcement discretion policy on 28 Oct 2026 (FR doc 2026-22192, published 30 Oct). Semax is one of six peptides in Appendix A. HHS says it will not act against licensed 503A compounding with a prescription, routes limited to intranasal only. Comments close 13 Nov 2026. source ↗ |
| 12 Oct 2026 | 503A Bulks List status | under pcac review | pcac recommended | Not eligible as of 12 Oct 2026. Removed from Category 2 on 15 Apr 2026; the PCAC recommended it on 24 Jul 2026. source ↗ |
| 12 Oct 2026 | FDA Category 2 (safety risk) | under pcac review | not on list | FDA's Category 2 page lists it under 'nominated but withdrawn', not in Category 2. source ↗ |
| 12 Oct 2026 | IN state note | none | added | Since 1 Jul 2026 Indiana law (IC 16-42-22.5) bars compounding from research-grade or veterinary-grade bulk ingredients outside an IRB-approved study and requires an FDA-registered source with a certificate of analysis. From 1 Jan 2027 medical spas must register with the state medical board. This matters if FDA later allows pharmacies to compound Semax: in Indiana the ingredient could not be research grade. source ↗ |
| 12 Oct 2026 | PCAC review | pending (vote scheduled) | voted yes | PCAC vote on 2026-07-24: 8 yes, 5 no, 1 abstention (law-firm reports). source ↗ |
Questions
3 ANSWERSIs Semax legal in the US?
Not as a drug. Semax has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. It is approved in Russia, which has no effect in the US. Under an interim HHS policy of 28 October 2026, a licensed pharmacy may compound it against a prescription, by set routes and under strict conditions, without federal enforcement. That policy does not cover research-use-only vials sold online.
Can a pharmacy compound Semax?
Still not on the 503A Bulks List and not an approved drug. Removed from Category 2 on 15 Apr 2026. On 24 Jul 2026 the PCAC recommended it for the Bulks List. On 28 Oct 2026 HHS issued an interim 'Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances' (Federal Register 30 Oct 2026, 91 FR 68526). HHS says it does not intend to take enforcement action against a state-licensed pharmacy, Federal facility or licensed physician compounding Semax against a patient-specific prescription, limited to intranasal only, as a single ingredient, from API made by an FDA-registered facility with a full certificate of analysis. The Federal Register notice calls the policy a draft that is not binding; comments close 13 Nov 2026 (docket HHS-OASH-2026-0496). It does not cover 503B outsourcing facilities or research-use-only vials sold online.
Is Semax banned in sport?
It is not on the WADA 2026 Prohibited List. Not named. Semax is approved in Russia, so S0 does not apply on its text. Check with your anti-doping organisation.